(SeaPRwire) – By: Oliver Hawthorne
The tech world chases flashy AI chatbots and viral demos. IBM isn’t playing that game. It’s quietly building a revenue juggernaut. Its focus? Solving real problems for big, regulated companies. This split between hype and substance created an investor blind spot. Until now. Wall Street is finally catching on. IBM’s stock climbed 2.3% to open at $277.83 this week. The driver? Quantum leadership and a surging AI backlog. Competitors focused on consumer AI are missing the largest, most profitable AI market segment.
Bank of America named IBM a quantum frontrunner on June 29. It cited IBM’s manufacturing base and progress tracking qubits, operations, and throughput. IBM’s recent quantum day showed it leads rivals in research documentation. It also launched the world’s first sub-1 nanometer chip this month. On the AI front, IBM’s strategy avoids flashy models. It helps enterprises plug AI into existing systems, data, and compliance frameworks. The numbers speak for themselves. Q1 2026 revenue hit $15.9 billion, up 9% year over year. Software revenue grew 11%, with recurring software revenue at $24.6 billion. Free cash flow reached $2.2 billion—IBM’s strongest Q1 in a decade. Generative AI makes up 30% of its consulting pipeline. Its AI book of business jumped from $7.5 billion to $12.5 billion in three quarters. Clients aren’t just asking questions. They’re signing contracts. IBM trades at a forward P/E of 26.41x. That’s a 20% discount to the sector median of 33.02x. Institutional investors are doubling down. Simmons Bank increased its stake by 16.7% in Q1, holding 15,660 shares worth $3.8 million. Other firms like Family CFO Inc and Basepoint Wealth opened new positions. Institutional and hedge fund ownership stands at 58.96%. IBM rewards shareholders too. It raised its quarterly dividend to $1.69 per share, paid June 10. That’s a 2.4% yield, marking 31 straight years of increases. Q1 earnings beat estimates: $1.91 EPS vs $1.81, $15.92 billion revenue vs $15.6 billion. Return on equity was 37.23%, net margin 15.61%. Analysts forecast full-year 2026 EPS of $12.39. Wall Street’s consensus is a Moderate Buy. One analyst rates it Strong Buy, 17 Buy, nine Hold. The average price target is $306.94, implying upside from current levels.
IBM’s commercial loop is built for longevity. Enterprises don’t want to rip out decades-old systems. They want AI that integrates seamlessly, without breaking compliance. IBM fills that gap. Its AI backlog growth proves this model works. Clients are locking in long-term contracts, ensuring steady recurring revenue. For quantum, IBM’s manufacturing base is a critical moat. Competitors struggle to scale qubit production. IBM’s ability to track and improve qubit performance puts it ahead. The end-game? IBM will dominate two high-margin sectors: regulated enterprise AI and quantum computing services. Investors are starting to see this. The stock’s discount won’t last. Institutional buying signals confidence in IBM’s quiet, steady approach. This isn’t a flash-in-the-pan rally. It’s the start of a sustained bull run as IBM’s dual moats solidify.
Author bio: Oliver Hawthorne, Principal Correspondent at TechGlobal Review, covers enterprise tech and emerging compute trends from Silicon Valley.